Status:
ACTIVE_NOT_RECRUITING
HPV Vaccine Reminders - SEARCH II Study
Lead Sponsor:
Columbia University
Collaborating Sponsors:
Makerere University
National Cancer Institute (NCI)
Conditions:
Human Papillomavirus Vaccination
Eligibility:
FEMALE
10-14 years
Phase:
NA
Brief Summary
This RCT will take place at health centres and their affiliated schools and community immunization centers overseen by the Kampala Capital City Authority (KCCA) as well as at the Makerere/Mulago/Colum...
Detailed Description
Cervical cancer is the leading female cancer in Uganda. HPV is the principal cause of cervical cancer. The national HPV vaccination program in Uganda includes preteen/ adolescent girls. Vaccinations a...
Eligibility Criteria
Inclusion
- Be a parenting adult of an adolescent girl aged 10-14 years
- Reside in Kampala and/or the surrounding districts
- Speak English or Luganda
- Have a cell phone with text messaging capability
- Must have ability to consent
Exclusion
- Parenting adult speaks other language than English or Luganda only
- Parenting adult already enrolled in the study for another child
- Participation in previous HPV vaccine reminder study
Key Trial Info
Start Date :
April 22 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 31 2026
Estimated Enrollment :
396 Patients enrolled
Trial Details
Trial ID
NCT06161831
Start Date
April 22 2024
End Date
July 31 2026
Last Update
September 8 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Columbia University Irving Medical Center
New York, New York, United States, 10032
2
Makerere University/Mulago Hospital
Kampala, Uganda